23
Publications
751
Citations
16
H-Index
1987
Active since
Beverly A. Teicher is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and oncology.
Top concepts
MedicinePharmacologyOncologyTumor BiologyCancer ResearchRadiation OncologyDrug ResistancePharmacotherapyBiochemistryCell Biology
Publications per year
1987–2001
23
23
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.
J P Eder, C Wheeler, Beverly A. Teicher et al. · PubMed · 1991 · 58 citations
Rows per page
1–5 of 23